NGM BIOPHARMACEUTICALS INC Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.91 | 37,800 | 676,998 | 374,269 | 336.5 K to 374.3 K (+11.23 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.91 | 33,896 | 607,077 | 336,469 | 302.6 K to 336.5 K (+11.20 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 18.00 | 3,751 | 67,518 | 302,573 | 298.8 K to 302.6 K (+1.26 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.91 | 37,800 | 676,998 | 374,269 | 336.5 K to 374.3 K (+11.23 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 17.91 | 33,896 | 607,077 | 336,469 | 302.6 K to 336.5 K (+11.20 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 18.00 | 3,751 | 67,518 | 302,573 | 298.8 K to 302.6 K (+1.26 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.91 | 37,800 | 676,998 | 16,541,176 | 16.5 M to 16.5 M (+0.23 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.91 | 33,896 | 607,077 | 16,503,376 | 16.5 M to 16.5 M (+0.21 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 18.00 | 3,751 | 67,518 | 16,469,480 | 16.5 M to 16.5 M (+0.02 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.91 | 37,800 | 676,998 | 16,731,176 | 16.7 M to 16.7 M (+0.23 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.91 | 33,896 | 607,077 | 16,693,376 | 16.7 M to 16.7 M (+0.20 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 18.00 | 3,751 | 67,518 | 16,659,480 | 16.7 M to 16.7 M (+0.02 %) |
Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 15.96 | 44,900 | 716,604 | 298,822 | 253.9 K to 298.8 K (+17.68 %) |
Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 15.96 | 44,900 | 716,604 | 16,465,729 | 16.4 M to 16.5 M (+0.27 %) |
Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 15.96 | 44,900 | 716,604 | 16,655,729 | 16.6 M to 16.7 M (+0.27 %) |
Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | Trombley Aetna Wun | President & COO | Option Exercise | A | 16.47 | 100,000 | 1,647,000 | 100,000 | |
Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | A | 16.47 | 175,000 | 2,882,250 | 175,000 | |
Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | A | 16.47 | 75,000 | 1,235,250 | 75,000 | |
Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | WOODHOUSE DAVID J | CEO and acting CFO | Option Exercise | A | 16.47 | 400,000 | 6,588,000 | 400,000 |